ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Indianapolis, IN, USA:

Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Sanofi
Sanofi

Indianapolis, Indiana, United States and 9 other locations

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes...

Not yet enrolling
Type 1 Diabetes (T1D)
Healthy Adult
Behavioral: phone call
Behavioral: email/mail
Indiana University
Indiana University

Indianapolis, Indiana, United States

for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plu...

Enrolling
Type 1 Diabetes Mellitus
Drug: Technosphere Insulin
Drug: Basal insulin

Phase 2

MannKind
MannKind

Indianapolis, Indiana, United States and 9 other locations

of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes...

Enrolling
Type 1 Diabetes
Gastroparesis Due to Diabetes Mellitus Type I
Device: Medtronic 780G AID
Viral N. Shah

Indianapolis, Indiana, United States

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...

Active, not recruiting
Type 1 Diabetes
Drug: DFMO
Drug: Placebo

Phase 2

Emily K. Sims

Indianapolis, Indiana, United States and 6 other locations

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Fishers, Indiana, United States and 96 other locations

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling
Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
Drug: CNP-103
Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

Indianapolis, Indiana, United States and 33 other locations

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Phase 3

vTv Therapeutics
vTv Therapeutics

Indianapolis, Indiana, United States and 59 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Indianapolis, Indiana, United States and 29 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Avon, Indiana, United States and 228 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems